Long survival in an elderly patient with acute myeloid leukaemia after treatment with harringtonine.
A remission was achieved in a 73-year-old woman with acute myeloid leukaemia after treatment with harringtonine. The remission lasted 3 1/2 years and she remained alive at the four-year follow-up.